Fetuin A Concentration in the Second Trimester Amniotic Fluid of Fetuses with Trisomy 21 Appears to Be Lower: Phenotypic Considerations

被引:8
|
作者
Iliodromiti, S. [1 ,2 ]
Vrachnis, N. [1 ]
Samoli, Evangelia [3 ]
Iliodromiti, Z. [1 ]
Pangalos, C. [4 ]
Drakoulis, N. [5 ]
Creatsas, G. [1 ]
Botsis, D. [1 ]
机构
[1] Univ Athens, Sch Med, Dept Obstet & Gynecol 2, Aretaie Hosp, Athens 11526, Greece
[2] W Scotland Deanery Obstet & Gynaecol, Glasgow G3 8BW, Lanark, Scotland
[3] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece
[4] Diagnost Genet Ctr, Athens 11528, Greece
[5] Univ Athens, Dept Pharmaceut Technol, Sch Pharm, GR-15771 Athens, Greece
关键词
DEVELOPING NEOCORTEX; OXIDATIVE STRESS; HS-GLYCOPROTEIN; FETAL; PLASMA; PREGNANCIES; EXPRESSION; ORIGIN;
D O I
10.1155/2012/138971
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective. We investigated whether the concentration of the glycoprotein fetuin A is altered in the second trimester amniotic fluid of trisomy 21 pregnancies compared with euploid pregnancies. Methods. 25 pregnancies with an extra chromosome 21 were matched for maternal and gestational age with 25 pregnancies with normal karyotype. Levels of fetuin A in amniotic fluid were measured by a commercially available enzyme-linked immunosorbent assay (ELISA) kit. Results. The median concentration of fetuin A in amniotic fluid of trisomy 21 pregnancies (5.3 ng/ml) was statistically significantly lower (P value = 0.008) compared with that in euploid pregnancies (6.8 ng/mL). Conclusion. Lower levels of fetuin A in trisomy 21 may indicate an association with altered metabolic pathways in this early stage that could potentially be associated with features of the syndrome, such as growth restriction or impaired osteogenesis.
引用
收藏
页数:4
相关论文
共 26 条
  • [21] Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth
    Ohnishi, Y
    Yamashiro, C
    Yanagihara, T
    Hata, T
    HUMAN REPRODUCTION, 1999, 14 (10) : 2625 - 2628
  • [22] A novel 21p+chromosome with duplication of Down syndrome critical region in the amniotic fluid cells of a second trimester pregnancy.
    Yenamandra, AK
    Trinchitella, L
    Haberman, G
    Perrone, R
    McKenna, C
    Bialer, M
    Koduru, P
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A363 - A363
  • [23] Trisomy 21 Mid-Trimester Amniotic Fluid Induced Pluripotent Stem Cells Maintain Genetic Signatures During Reprogramming: Implications for Disease Modeling and Cryobanking
    Pipino, Caterina
    Mukherjee, Sayandip
    David, Anna L.
    Blundell, Michael P.
    Shaw, Steven W.
    Sung, Peggy
    Shangaris, Panicos
    Waters, Jonathan J.
    Ellershaw, Drew
    Cavazzana, Marina
    Mostoslavsky, Gustavo
    Pandolfi, Assunta
    Pierro, Agostino
    Guillot, Pascale V.
    Thrasher, Adrian J.
    De Coppi, Paolo
    CELLULAR REPROGRAMMING, 2014, 16 (05) : 331 - 344
  • [24] Trisomy 21 mid-trimester amniotic fluid iPS cells maintain genetic signatures during reprogramming: implications for disease modelling and cryo-banking
    Mukherjee, Sayandip
    Pipino, Caterina
    David, Anna
    Blundell, Michael
    DeCoppi, Paolo
    Thrasher, Adrian
    HUMAN GENE THERAPY, 2013, 24 (05) : A19 - A19
  • [25] Ethical considerations of early (first vs. second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing
    Sharma, Geeta
    McCullough, Laurence B.
    Chervenak, Frank A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2007, 145C (01) : 99 - 104
  • [26] Subsequent gestational diabetes mellitus prediction in advanced maternal age using amniotic fluid glucose concentration during second trimester genetic amniocentesis
    Hanprasertpong, Tharangrut
    Kor-Anantakul, Ounjai
    Suwanrath, Chitkasaem
    Suntharasaj, Thitima
    Pruksanusak, Ninlapa
    Hanprasertpong, Jitti
    Geater, Alan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 36 (06) : 744 - 747